Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15876 | 618 | 38.5 | 80% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1091 | 9322 | OSTEOGENESIS IMPERFECTA//EHLERS DANLOS SYNDROME//EHLERS DANLOS SYNDROME TYPE IV |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BETHLEM MYOPATHY | Author keyword | 50 | 84% | 4% | 27 |
2 | COLLAGEN VI | Author keyword | 47 | 58% | 9% | 54 |
3 | TYPE VI COLLAGEN | Author keyword | 39 | 49% | 10% | 59 |
4 | ULLRICH CONGENITAL MUSCULAR DYSTROPHY | Author keyword | 27 | 76% | 3% | 19 |
5 | NG2 PROTEOGLYCAN | Author keyword | 11 | 52% | 2% | 15 |
6 | COLLAGEN TYPE VI | Author keyword | 8 | 41% | 3% | 16 |
7 | COL6A2 | Author keyword | 8 | 100% | 1% | 5 |
8 | ULLRICHS DISEASE | Author keyword | 8 | 100% | 1% | 5 |
9 | MED SURG CLIN CARE | Address | 4 | 75% | 0% | 3 |
10 | TRIPLE HELICAL DOMAIN | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BETHLEM MYOPATHY | 50 | 84% | 4% | 27 | Search BETHLEM+MYOPATHY | Search BETHLEM+MYOPATHY |
2 | COLLAGEN VI | 47 | 58% | 9% | 54 | Search COLLAGEN+VI | Search COLLAGEN+VI |
3 | TYPE VI COLLAGEN | 39 | 49% | 10% | 59 | Search TYPE+VI+COLLAGEN | Search TYPE+VI+COLLAGEN |
4 | ULLRICH CONGENITAL MUSCULAR DYSTROPHY | 27 | 76% | 3% | 19 | Search ULLRICH+CONGENITAL+MUSCULAR+DYSTROPHY | Search ULLRICH+CONGENITAL+MUSCULAR+DYSTROPHY |
5 | NG2 PROTEOGLYCAN | 11 | 52% | 2% | 15 | Search NG2+PROTEOGLYCAN | Search NG2+PROTEOGLYCAN |
6 | COLLAGEN TYPE VI | 8 | 41% | 3% | 16 | Search COLLAGEN+TYPE+VI | Search COLLAGEN+TYPE+VI |
7 | COL6A2 | 8 | 100% | 1% | 5 | Search COL6A2 | Search COL6A2 |
8 | ULLRICHS DISEASE | 8 | 100% | 1% | 5 | Search ULLRICHS+DISEASE | Search ULLRICHS+DISEASE |
9 | TRIPLE HELICAL DOMAIN | 4 | 75% | 0% | 3 | Search TRIPLE+HELICAL+DOMAIN | Search TRIPLE+HELICAL+DOMAIN |
10 | LONG SPACING COLLAGEN | 4 | 56% | 1% | 5 | Search LONG+SPACING+COLLAGEN | Search LONG+SPACING+COLLAGEN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BETHLEM MYOPATHY | 69 | 60% | 12% | 75 |
2 | GLOBULAR DOMAINS | 50 | 52% | 11% | 68 |
3 | COL6A1 GENE | 48 | 100% | 3% | 17 |
4 | ULLRICH DISEASE | 41 | 100% | 2% | 15 |
5 | INTIMA COLLAGEN | 40 | 82% | 4% | 23 |
6 | ALPHA 3VI CHAIN | 38 | 93% | 2% | 14 |
7 | LIMB GIRDLE MYOPATHY | 20 | 100% | 1% | 9 |
8 | ALPHA 2VI CHAINS | 14 | 100% | 1% | 7 |
9 | ALPHA 3 CHAIN | 13 | 26% | 7% | 45 |
10 | IN FRAME DELETION | 12 | 47% | 3% | 18 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Ullrich congenital muscular dystrophy: clinicopathological features, natural history and pathomechanism(s) | 2015 | 1 | 56 | 77% |
The collagen VI-related myopathies: muscle meets its matrix | 2011 | 43 | 110 | 75% |
Collagen VI related muscle disorders | 2005 | 174 | 114 | 81% |
ColVI myopathies: where do we stand, where do we go? | 2011 | 26 | 103 | 76% |
The expanded collagen VI family: new chains and new questions | 2013 | 5 | 40 | 70% |
Collagen VI in cancer and its biological mechanisms | 2013 | 9 | 81 | 35% |
Therapy of collagen VI-related myopathies (Bethlem and Ullrich) | 2008 | 14 | 30 | 67% |
CSPG4 in Cancer: Multiple Roles | 2010 | 34 | 55 | 27% |
Theranostic Impact of NG2/CSPG4 Proteoglycan in Cancer | 2015 | 0 | 150 | 37% |
Functional and Clinical Relevance of Chondroitin Sulfate Proteoglycan 4 | 2010 | 22 | 162 | 22% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED SURG CLIN CARE | 4 | 75% | 0.5% | 3 |
2 | COMT MOL TRANSLAT ONCOL | 3 | 50% | 0.6% | 4 |
3 | MUSCULOSKELETAL CELL BIOL | 2 | 19% | 1.5% | 9 |
4 | NEUROMUSCULAR NEUROGENET DISORDERS CHILDHOOD SE | 2 | 26% | 1.0% | 6 |
5 | CARDIOGENET MYOGENET FUNCT UNIT | 1 | 50% | 0.3% | 2 |
6 | NEUROSCI MOL MED | 1 | 50% | 0.3% | 2 |
7 | SOC EXPT ONCOL 2 | 1 | 50% | 0.3% | 2 |
8 | CANC AVIANO | 1 | 33% | 0.5% | 3 |
9 | NEUROMUSCULAR PATHOL | 1 | 20% | 0.8% | 5 |
10 | EXPT NEUROONCOL GRP | 1 | 30% | 0.5% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000195789 | COLLAGEN XVI//TYPE XI COLLAGEN//COLLAGEN XII |
2 | 0.0000192264 | RIGID SPINE SYNDROME//RIGID SPINE//EMERINOPATHY |
3 | 0.0000102288 | CONGENITAL MUSCULAR DYSTROPHY//DYSTROGLYCAN//MUSCLE EYE BRAIN DISEASE |
4 | 0.0000067506 | LARP6//ALPHA 2I COLLAGEN//DERIVATIVE OF ERYTHROMYCIN |
5 | 0.0000060679 | POLYVALENT ANTIGEN//AUTOLOGOUS ANTIBODY//B700 |
6 | 0.0000059484 | PERICYTES//PERICYTE//BOVINE RETINAL PERICYTES |
7 | 0.0000055774 | JUVENILE HYALINE FIBROMATOSIS//INFANTILE SYSTEMIC HYALINOSIS//SYSTEMIC HYALINOSIS |
8 | 0.0000052875 | DECORIN//LUMICAN//BIGLYCAN |
9 | 0.0000052761 | FRASER SYNDROME//CRYPTOPHTHALMOS//FRAS1 |
10 | 0.0000051441 | MARFAN SYNDROME//FIBRILLIN//FBN1 |